延伸閱讀
- Ohka, F., Natsume, A., & Wakabayashi, T. (2012). Current Trends in Targeted Therapies for Glioblastoma Multiforme. Neurology Research International, 2012(), 543-555. https://doi.org/10.1155/2012/878425
- Chu, C. W. (2019). Drug Repositioning for Potential Effective Glioblastoma Treatment [doctoral dissertation, Kaohsiung Medical University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0011-2705201914372400
- Gil, M. J. G., Mesia, C., Rey, M., & Bruna, J. (2013). Bevacizumab for the Treatment of Glioblastoma. Clinical Medicine Insights: Oncology, (), 123-135. https://doi.org/10.4137/CMO.S8503
- Lan, T. L., & Lan, C. C. (2021). Use of Tumor-Treating Fields for Glioblastoma: Overview of a Novel Treatment Modality. The Changhua Journal of Medicine, 19(4), 170-174. https://doi.org/10.6501/CJM.202112_19(4).0006
- Sungarian, A., Cielo, D., Sampath, P., Bowling, N., Moskal, P., Wands, J. R., & Monte, S. M. D. L. (2009). Potential Role of Thymosin-α1 Adjuvant Therapy for Glioblastoma. Journal of Oncology, 2009(), 79-89. https://doi.org/10.1155/2009/302084